Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Roche won't revisit Illumina, eyes smaller deals
Reuters
Sun, 06/10/12 - 11:09 am
Roche
Illumina
M&A
CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
Fri, 06/8/12 - 12:55 pm
CareFusion
UK
M&A
UK Medical Limited
Glaxo Adds Three More Weeks For Human Genome Tender
WSJ Online
Fri, 06/8/12 - 09:46 am
GSK
Human Genome Sciences
M&A
CareFusion announces agreement to resell Codonics technology
Wed, 06/6/12 - 11:25 pm
CareFusion
contract
M&A
Codonics
technology
Mindray Medical to Acquire Controlling Stake in Dragonbio's Orthopedics Business for US$35.5 Million
Wed, 06/6/12 - 11:23 pm
Mindray
M&A
Dragonbio Orthopedics
Eli Lilly CEO Says No Big Deals
WSJ Online
Wed, 06/6/12 - 05:29 pm
John Lechleiter
Pharma CEOs
Eli Lilly
M&A
Human Genome Sciences And GlaxoSmithKline: When A Marriage Goes Sour
Seeking Alpha
Wed, 06/6/12 - 10:47 am
GSK
Human Genome Sciences
M&A
LabCorp grabs Medtox for $241M
Tue, 06/5/12 - 10:37 pm
LabCorp
Medtox
M&A
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tue, 06/5/12 - 09:39 am
Amylin
M&A
Sanofi
AstraZeneca
Merck
Bristol-Myers Squibb
Bad Romance: Glaxo's Brutal Courtship of Human Genome Sciences
TheStreet.com
Mon, 06/4/12 - 10:53 am
GSK
M&A
Human Genome Sciences
Is Sun Pharma getting back on the acquisition track?
Live Mint
Sun, 06/3/12 - 01:47 pm
Sun Pharma
M&A
AstraZeneca bids $4bn for diabetes specialist Amylin
Telegraph, UK
Sun, 06/3/12 - 01:45 pm
AstraZeneca
Amylin
M&A
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sun, 06/3/12 - 12:23 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
Merck has no plans to sell animal and consumer health businesses
NJ.com
Fri, 06/1/12 - 10:32 am
Merck
animal health
M&A
OTC
Forest Laboratories and Nabriva Therapeutics Sign Agreement
Yahoo
Fri, 06/1/12 - 10:28 am
Forest Labs
Nabriva Therapeutics
BC-3781
M&A
Human Genome Sciences Takeover Defense Survives Court Test
Bloomberg
Thu, 05/31/12 - 06:13 pm
Human Genome Sciences
GSK
M&A
hostile bid
The Race For Amylin Kicks Into High-Gear
Seeking Alpha
Wed, 05/30/12 - 03:01 pm
Amylin
M&A
AstraZeneca
Bristol-Myers Squibb
Pfizer
Exclusive: GSK eyes replacing Human Genome board: sources
Reuters
Wed, 05/30/12 - 10:29 am
GSK
Human Genome Sciences
M&A
hostile bid
Who Should Buy Amylin?
Motley Fool
Tue, 05/29/12 - 04:44 pm
M&A
Amylin
Sanofi
Merck
Bristol-Myers Squibb
Takeda
AstraZeneca
Human Genome shareholder sues board over GSK "poison pill," Reuters reports
Yahoo/Fly on the Wall
Tue, 05/29/12 - 11:11 am
Human Genome Sciences
GSK
poison pill
M&A
Pages
« first
‹ previous
…
238
239
240
241
242
243
244
245
246
…
next ›
last »